Androgenetic hair loss and modern therapeutic concepts;Anlagebedingter haarausfall und aktuelle therapiekonzepte

Aktuelle Dermatologie

Volumn 28, Issue SUPPL. 1, 2002, Pages

  Blume Peytavi, Ulrike ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANTIFIBROTIC AGENT; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT;

ALOPECIA; ARTICLE; FIBROSIS; GENETIC PREDISPOSITION; HAIR LOSS; HORMONAL THERAPY; INFLAMMATION; PATHOGENESIS; SEBORRHEA; VASCULARIZATION;

EID: 0036895389     PISSN: 03402541     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-35410     Document Type: Article

References (23)

1. Hamilton JB. Patterned hair loss in man: Types and incidence. Ann N Y Acad Sci 1951; 53: 708-728
2. Ludwig E. Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex. Br J Dermatol 1977; 97: 247-254
3. Olsen EA. The midline part: An important physical clue to the clinical diagnosis of androgenetic alopecia in women. J Am Acad Dermatol 1999; 40: 106-109
4. Sawaya M, Price V. Different levels of 5α-reductase type I and II, aromatase, and androgen receptor in hair follicles of women and men with androgenetic alopecia. J Invest Dermatol 1997; 109: 296-300
5. Orfanos CE, Garbe C (Hrsg). Häufige haarkrankheiten. In: Therapie der Hautkrankheiten. Springer Verlag, 2002: 1396-1422
6. Kozlowska U, Blume-Peytavi U, Kodelja V, Sommer C, Goerdt S, Jablonska S, Orfanos CE. Vascular endothelial growth factor induced by proinflammatory cytokines (IL-1α, β) in cells of the human pilosebaceous unit. Dermatology 1998; 196: 89-92
7. Lattanad A, Johnson WC. Male pattern alopecia. A histopathologic and histochemical study. J Cutaneous Pathology 1975; 2: 58-70
8. Arck PC, Handjiski B, Hagen B, Hagen E, Joachim R, Klapp BF, Paus R. Indications for a "brain-hair follicle axis (BHA)": Inhibition of keratinocyte proliferation and up-regulation of keratinocyte apoptosis in telogen hair follicles by stress and substance P. FASEB J 2001; 15: 2536-2538
9. Kozlowska U, Blume-Peytavi U, Kodelja V, Sommer C, Majewski S, Jablonska S, Goerdt S, Orfanos CE. Vascular endothelial growth factor expression in various compartments of the human hair follicle. Arch Derm Res 1998; 290: 661-668
10. Lachgar S, Monkadiri H, Jonca F, Charveron M, Bouhaddioui N, Gall Y, Bonafe JL, Plouet J. Vascular endothelial factor is an autocrine growth factor for hair dermal papilla cells. J Invest Dermatol 1996; 106: 17-23
11. Wolf R, Schönfelder G, Paul M, Blume-Peytavi U. Nitric oxide in the human hair follicle: Constitutive and dihydrotestosterone induced nitric oxide synthase expression and NO production in dermal papilla cells. J Mol Med 2002: in press
12. Orfanos CE, Vogels L. Local therapy of androgenetic alopecia with 17 alpha-estradiol. A controlled randomized double-blind study. Dermatologica 1980; 161: 124-132
13. Oh HS, Smart RC. An estrogen receptor pathway regulates the telogenanagen hair-follicle transition and influences epidermal cell proliferation. N Proc Acad Sci 1996; 93: 12 525-12 530
14. Smart RC, Oh HS. On the effect of estrogen receptor agonists and antagonists on the mouse hair follicle cycle. J Invest Dermatol 1998; 111: 175
15. Kaufman KD, Olsen EA, Whiting D et al. Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group. J Am Acad Dermatol 1998; 39: 578-589
16. Price VH, Roberts JL, Hordinsky M et al. Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia. J Am Acad Dermatol 2000; 43: 768-776
17. Lachgar S, Charveron M, Gall Y, Bonafe JL. Minoxidil upregulates the expression of vascular endothelial growth factor in human hair dermal papilla cells. Br J Dermatol 1998; 38: 407-411
18. Connors TJ, Cooke TE, De Launey WE et al. Australian trial of topical minoxidil and placebo in early male pattern baldness. Australas J Dermatol 1990; 31: 17-25
19. de Groot AC, Nater JP, Herxheimer A. Minoxidil for male-pattern baldness. Lancet 1987; 2: 563
20. de Groot AC, Nater JP, Herxheimer A. Minoxidil: Hope for the bald? Lancet 1987; 1: 1019-1022
21. Koperski JA, Orenberg EK, Wilkinson DI. Topical minoxidil therapy for androgenetic alopecia. A 30-month study. Arch Dermatol 1987; 123: 1483-1487
22. Data on File (Data on File, Vichy-Cosmétique Active Deutschland/L'Oréal)
23. Herel H, Gollnick H, Matthies C, Baumann I, Orfanos LE. Low dosage retinol and L-cystine combination improve alopecia of the diffuse type following long-term oral administration. Hautarzt 1989; 40 (8): 490-495